Cramer Shares His Thoughts On Teva, Oxford Industries And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said he wouldn't buy Teva Pharmaceutical Industries Ltd (NYSE: TEVA). He explained that it's a generic drugmaker and those stocks are pretty awful in comparison to Merck & Co., Inc. (NYSE: MRK), Pfizer Inc. (NYSE: PFE) and Bristol-Myers Squibb Co (NYSE: BMY).
Instead of Oxford Industries Inc (NYSE: OXM), Cramer would rather buy PVH Corp (NYSE: PVH).
Cramer likes Amgen, Inc. (NASDAQ: AMGN) and its new oncological franchise.
He prefers Advanced Micro Devices, Inc. (NASDAQ: AMD) over Intel Corporation (NASDAQ: INTC). He believes AMD will take some market share from Intel with its new chips.
Cramer said the CEO of General Electric Company (NYSE: GE) is doing a fantastic job against tremendous circumstances, but he doesn't see the investment in the stock as a diversification strategy.
Cramer likes SpartanNash Co (NASDAQ: SPTN) a lot. He thinks that something must be going on and he sees the stock as a good one.
He would sell a half of a position in Ingevity Corp (NYSE: NGVT) and let the rest run.
See more from Benzinga
Cramer Weighs In On Beyond Meat, Canopy Growth, Penn National And More
Cramer Gives His Opinion On GW Pharma, Bed Bath & Beyond And More
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.